These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26446462)

  • 1. Numerical Modelling of Agglomeration and Deagglomeration in Dry Powder Inhalers: A Review.
    Yang J; Wu CY; Adams M
    Curr Pharm Des; 2015; 21(40):5915-22. PubMed ID: 26446462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review.
    Tong Z; Yu A; Chan HK; Yang R
    Curr Pharm Des; 2015; 21(27):3966-73. PubMed ID: 26290194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler.
    Zhu Q; Kakhi M; Jayasundara C; Walenga R; Behara SRB; Chan HK; Yang R
    Int J Pharm; 2023 Nov; 647():123556. PubMed ID: 37890648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-scale modelling of powder dispersion in a carrier-based inhalation system.
    Tong Z; Kamiya H; Yu A; Chan HK; Yang R
    Pharm Res; 2015 Jun; 32(6):2086-96. PubMed ID: 25511919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational investigation of particle penetration and deposition pattern in a realistic respiratory tract model from different types of dry powder inhalers.
    Kim YH; Li DD; Park S; Yi DS; Yeoh GH; Abbas A
    Int J Pharm; 2022 Jan; 612():121293. PubMed ID: 34808267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsule-Based dry powder inhaler evaluation using CFD-DEM simulations and next generation impactor data.
    Almeida LC; Bharadwaj R; Eliahu A; Wassgren CR; Nagapudi K; Muliadi AR
    Eur J Pharm Sci; 2022 Aug; 175():106226. PubMed ID: 35643378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of computational fluid dynamics in inhaler design.
    Ruzycki CA; Javaheri E; Finlay WH
    Expert Opin Drug Deliv; 2013 Mar; 10(3):307-23. PubMed ID: 23289401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Devices for dry powder drug delivery to the lung.
    Berkenfeld K; Lamprecht A; McConville JT
    AAPS PharmSciTech; 2015 Jun; 16(3):479-90. PubMed ID: 25964142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided design of dry powder inhalers using computational fluid dynamics to assess performance.
    Suwandecha T; Wongpoowarak W; Srichana T
    Pharm Dev Technol; 2016; 21(1):54-60. PubMed ID: 25265389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the optimisation and adaptation of dry powder inhalers.
    Cui Y; Schmalfuß S; Zellnitz S; Sommerfeld M; Urbanetz N
    Int J Pharm; 2014 Aug; 470(1-2):120-32. PubMed ID: 24792975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Texture and Surface Chemistry on Deagglomeration and Powder Retention in Capsule-Based Dry Powder Inhaler.
    Groß R; Berkenfeld K; Schulte C; Ebert A; Sule S; Sule A; Lamprecht A
    AAPS PharmSciTech; 2022 Oct; 23(7):281. PubMed ID: 36241775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical Study on Particle Adhesion in Dry Powder Inhaler Device.
    Mitani R; Ohsaki S; Nakamura H; Watano S
    Chem Pharm Bull (Tokyo); 2020; 68(8):726-736. PubMed ID: 32741913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Use of Computational Fluid Dynamics (CFD) Modelling to Design Improved Dry Powder Inhalers.
    Fletcher DF; Chaugule V; Gomes Dos Reis L; Young PM; Traini D; Soria J
    Pharm Res; 2021 Feb; 38(2):277-288. PubMed ID: 33575958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle-based coarse-grained approach for simulating dry powder inhaler.
    Liu X; Sulaiman M; Kolehmainen J; Ozel A; Sundaresan S
    Int J Pharm; 2021 Sep; 606():120821. PubMed ID: 34171427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational modelling and experimental validation of drug entrainment in a dry powder inhaler.
    Kopsch T; Murnane D; Symons D
    Int J Pharm; 2018 Dec; 553(1-2):37-46. PubMed ID: 30316002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations.
    Benque B; Khinast JG
    Eur J Pharm Sci; 2021 Jan; 156():105574. PubMed ID: 32980431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier particle emission and dispersion in transient CFD-DEM simulations of a capsule-based DPI.
    Benque B; Khinast JG
    Eur J Pharm Sci; 2022 Jan; 168():106073. PubMed ID: 34774996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.